Oral drug delivery research in Europe

Research output: Contribution to journalArticle

50 Citations (Scopus)
66 Downloads (Pure)

Abstract

The oral delivery of drugs is considered by decision-makers in the pharmaceutical industry to be the most appealing route of administration. This belief has led to the identification of many very successful drugs, but also to the downfall of some promising therapeutics that failed to meet criteria required for sufficient oral bioavailability. Efforts to correct these deficiencies have led to a plethora of creative strategies to overcome the physical, chemical, and biological barriers that limit the efficient and consistent delivery of drugs that are not readily absorbed following oral administration. The goal of this perspective is to describe these barriers to oral drug delivery in relation to some of the work currently being undertaken by the community of European scientists. This perspective is not intended to be inclusive and the author apologizes in advance to the many scientists working in Europe whose recent work was not included.
Original languageEnglish
Pages (from-to)247-253
JournalJournal of Controlled Release
Volume161
Issue number2
DOIs
Publication statusPublished - 20 Jul 2012

Fingerprint

Research
Pharmaceutical Preparations
Drug Industry
European Union
Biological Availability
Oral Administration
Therapeutics

Cite this

Oral drug delivery research in Europe. / Mrsny, Randall J.

In: Journal of Controlled Release, Vol. 161, No. 2, 20.07.2012, p. 247-253.

Research output: Contribution to journalArticle

@article{0b34b4f9f7744aa7bab09207b75dac84,
title = "Oral drug delivery research in Europe",
abstract = "The oral delivery of drugs is considered by decision-makers in the pharmaceutical industry to be the most appealing route of administration. This belief has led to the identification of many very successful drugs, but also to the downfall of some promising therapeutics that failed to meet criteria required for sufficient oral bioavailability. Efforts to correct these deficiencies have led to a plethora of creative strategies to overcome the physical, chemical, and biological barriers that limit the efficient and consistent delivery of drugs that are not readily absorbed following oral administration. The goal of this perspective is to describe these barriers to oral drug delivery in relation to some of the work currently being undertaken by the community of European scientists. This perspective is not intended to be inclusive and the author apologizes in advance to the many scientists working in Europe whose recent work was not included.",
author = "Mrsny, {Randall J.}",
year = "2012",
month = "7",
day = "20",
doi = "10.1016/j.jconrel.2012.01.017",
language = "English",
volume = "161",
pages = "247--253",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Oral drug delivery research in Europe

AU - Mrsny, Randall J.

PY - 2012/7/20

Y1 - 2012/7/20

N2 - The oral delivery of drugs is considered by decision-makers in the pharmaceutical industry to be the most appealing route of administration. This belief has led to the identification of many very successful drugs, but also to the downfall of some promising therapeutics that failed to meet criteria required for sufficient oral bioavailability. Efforts to correct these deficiencies have led to a plethora of creative strategies to overcome the physical, chemical, and biological barriers that limit the efficient and consistent delivery of drugs that are not readily absorbed following oral administration. The goal of this perspective is to describe these barriers to oral drug delivery in relation to some of the work currently being undertaken by the community of European scientists. This perspective is not intended to be inclusive and the author apologizes in advance to the many scientists working in Europe whose recent work was not included.

AB - The oral delivery of drugs is considered by decision-makers in the pharmaceutical industry to be the most appealing route of administration. This belief has led to the identification of many very successful drugs, but also to the downfall of some promising therapeutics that failed to meet criteria required for sufficient oral bioavailability. Efforts to correct these deficiencies have led to a plethora of creative strategies to overcome the physical, chemical, and biological barriers that limit the efficient and consistent delivery of drugs that are not readily absorbed following oral administration. The goal of this perspective is to describe these barriers to oral drug delivery in relation to some of the work currently being undertaken by the community of European scientists. This perspective is not intended to be inclusive and the author apologizes in advance to the many scientists working in Europe whose recent work was not included.

UR - http://www.scopus.com/inward/record.url?scp=84862684767&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1016/j.jconrel.2012.01.017

U2 - 10.1016/j.jconrel.2012.01.017

DO - 10.1016/j.jconrel.2012.01.017

M3 - Article

VL - 161

SP - 247

EP - 253

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 2

ER -